UPDATE: Haemonetics (HAE) Initiated with 'Sell' Rating at Off Wall Street, PT $24

October 14, 2016 9:52 AM EDT
Get Alerts HAE Hot Sheet
Price: $39.51 --0%

Rating Summary:
    2 Buy, 11 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 3 | Down: 5 | New: 17
Trade HAE Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
(Updated - October 14, 2016 10:42 AM EDT)

Haemonetics (NYSE: HAE) was initiated with a Strong Sell recommendation at Off Wall Street, according to contacts. The stock was given a price target of $24, implying downside of 34%. Analysts said plasma revenue is unlikely to meet consensus. The report also noted that China is believed to be taking share, and public awareness is increasing regarding the risks of blood transfusion.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Short Sales

Add Your Comment